Patents by Inventor CHONG-JEN YU

CHONG-JEN YU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD AND KIT FOR MONITORING NON-SMALL CELL LUNG CANCER
    Publication number: 20240068043
    Abstract: Provided is a method for diagnosing and monitoring progression of cancer or effectiveness of a therapeutic treatment. The method includes detecting a methylation level of at least one gene in a biological sample containing circulating free DNA. Also provided are primer pairs and probes for diagnosis or prognosis of cancer in a subject in need thereof.
    Type: Application
    Filed: March 1, 2022
    Publication date: February 29, 2024
    Applicant: NATIONAL TAIWAN UNIVERSITY
    Inventors: Hsing-Chen TSAI, Chong-Jen YU, Hsuan-Hsuan LU, Shu-Yung LIN, Yi-Jhen HUANG, Chen-Yuan DONG
  • METHOD FOR TREATING CANCER
    Publication number: 20220226378
    Abstract: Provided herein are methods for treating or ameliorating malignant diseases, such as cancers. Also provided herein are methods of increasing the immunity of an immune cell toward malignant cells.
    Type: Application
    Filed: January 19, 2022
    Publication date: July 21, 2022
    Inventors: Hsing-Chen Tsai, Chien-Ting Lin, Chong-Jen Yu, Tai-Chung Huang, Rueyhung Roc Weng, Hsuan-Hsuan Lu, Jung-Chi Liao
  • Lung cancer biomarker
    Patent number: 10048264
    Abstract: The present invention relates to a lung cancer biomarker for diagnosing early stage lung cancers or predicting prognosis of lung cancers, which comprises a GM2AP protein. The present invention also relates to a method for diagnosing early stage lung cancers or predicting prognosis of lung cancers in vitro by detection of the biomarker.
    Type: Grant
    Filed: November 12, 2014
    Date of Patent: August 14, 2018
    Assignees: ACADEMIA SINICA, NATIONAL TAIWAN UNIVERSITY
    Inventors: Shui-Tein Chen, Chong-Jen Yu, Potprommanee Laddawan, Haou-Tzong Ma
  • LUNG CANCER BIOMARKER
    Publication number: 20160109452
    Abstract: The present invention relates to a lung cancer biomarker for diagnosing early stage lung cancers or predicting prognosis of lung cancers, which comprises a GM2AP protein. The present invention also relates to a method for diagnosing early stage lung cancers or predicting prognosis of lung cancers in vitro by detection of the biomarker.
    Type: Application
    Filed: November 12, 2014
    Publication date: April 21, 2016
    Inventors: SHUI-TEIN CHEN, CHONG-JEN YU, POTPROMMANEE LADDAWAN, HAOU-TZONG MA